EV/EBITDA
-0.71
-0.11-18.33%
Fri, 29 Nov 2024 21:43:28 GMT
Summary:
Aligos Therapeutics EV/EBITDA is currently -0.71, with a fall of -0.11 (-18.33%) during the most recent trading day. Over the past year, it has dropped by -0.79 (-987.50%). ALGS EV/EBITDA is now -178.89% below its all-time high of 0.90.ALGS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALGS EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -18.3% |
| 1 m1 month | -1320.0% |
| 3 m3 months | -914.3% |
| 6 m6 months | -73.2% |
| ytdytd | -180.7% |
| 1 y1 year | -987.5% |
| 5 y5 years | - |
ALGS EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -0.05 | -1320.0% | -0.71 | at low |
| 3 m | 3 months | 0.11 | -745.5% | -0.71 | at low |
| 6 m | 6 months | 0.11 | -745.5% | -0.71 | at low |
| 1 y | 1 year | 0.90 | -178.9% | -0.85 | +16.5% |
| 3 y | 3 years | 0.90 | -178.9% | -3.52 | +79.8% |
| 5 y | 5 years | 0.90 | -178.9% | -15.58 | +95.4% |
| alltime | all time | 0.90 | -178.9% | -15.58 | +95.4% |
Aligos Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | -0.71(-180.7%) |
| 2023 | 0.88(+193.3%) |
| Date | Value |
|---|---|
| 2022 | 0.30(-111.2%) |
| 2021 | -2.68(-68.5%) |
| 2020 | -8.51 |
FAQ
- What is Aligos Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Aligos Therapeutics?
- What is ALGS EV/EBITDA year-to-date change?
- What is Aligos Therapeutics EV/EBITDA year-on-year change?
What is Aligos Therapeutics EV/EBITDA?
The current EV/EBITDA of ALGS is -0.71
What is the all time high EV/EBITDA for Aligos Therapeutics?
Aligos Therapeutics all-time high EV/EBITDA is 0.90
What is ALGS EV/EBITDA year-to-date change?
Aligos Therapeutics EV/EBITDA has changed by -1.59 (-180.68%) since the beginning of the year
What is Aligos Therapeutics EV/EBITDA year-on-year change?
Over the past year, ALGS EV/EBITDA has changed by -0.79 (-987.50%)